Medtronic (MDT) Change in Accured Expenses (2014 - 2026)

Medtronic has disclosed Change in Accured Expenses across 13 years of filings, most recently posting $703.0 million for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $703.0 million, up 27.82% year-over-year; the trailing twelve-month figure through Jan 2026 was $289.0 million (down 40.66% YoY), and the FY2025 annual result was $209.0 million, down 46.55% from the prior year.
• Change in Accured Expenses came in at $703.0 million for Q1 2026 at Medtronic, up from -$182.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $703.0 million in Q1 2026 to a low of -$673.0 million in Q3 2023.
• The 5-year median for Change in Accured Expenses is $177.0 million (2023), against an average of $110.5 million.
• Across the five-year window, Change in Accured Expenses jumped 10250.0% in 2022 and plunged 357.82% in 2023, its largest moves.
• Medtronic's Change in Accured Expenses stood at $133.0 million in 2022, then slumped by 119.55% to -$26.0 million in 2023, then plunged by 296.15% to -$103.0 million in 2024, then sank by 76.7% to -$182.0 million in 2025, then jumped by 486.26% to $703.0 million in 2026.
• The last three Change in Accured Expenses figures came in at $703.0 million (Q1 2026), -$182.0 million (Q4 2025), and -$598.0 million (Q3 2025), per Business Quant data.